Strategies for Diagnosis and Treatment of Suspected Leptospirosis: A Cost-Benefit Analysis
Open Access
- 23 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 4 (2) , e610
- https://doi.org/10.1371/journal.pntd.0000610
Abstract
Symptoms and signs of leptospirosis are non-specific. Several diagnostic tests for leptospirosis are available and in some instances are being used prior to treatment of leptospirosis-suspected patients. There is therefore a need to evaluate the cost-effectiveness of the different treatment strategies in order to avoid misuse of scarce resources and ensure best possible health outcomes for patients. The study population was adult patients, presented with uncomplicated acute febrile illness, without an obvious focus of infection or malaria or typical dengue infection. We compared the cost and effectiveness of 5 management strategies: 1) no patients tested or given antibiotic treatment; 2) all patients given empirical doxycycline treatment; patients given doxycycline when a patient is tested positive for leptospirosis using: 3) lateral flow; 4) MCAT; 5) latex test. The framework used is a cost-benefit analysis, accounting for all direct medical costs in diagnosing and treating patients suspected of leptospirosis. Outcomes are measured in length of fever after treatment which is then converted to productivity losses to capture the full economic costs. Empirical doxycycline treatment was the most efficient strategy, being both the least costly alternative and the one that resulted in the shortest duration of fever. The limited sensitivity of all three diagnostic tests implied that their use to guide treatment was not cost-effective. The most influential parameter driving these results was the cost of treating patients with complications for patients who did not receive adequate treatment as a result of incorrect diagnosis or a strategy of no-antibiotic-treatment. Clinicians should continue treating suspected cases of leptospirosis on an empirical basis. This conclusion holds true as long as policy makers are not prioritizing the reduction of use of antibiotics, in which case the use of the latex test would be the most efficient strategy. Symptoms and signs of leptospirosis are non-specific. A number of diagnostic tests for leptospirosis are available. We compared the cost-benefit of 5 management strategies: 1) no patients tested or given antibiotic treatment; 2) all patients given empirical doxycycline treatment; patients given doxycycline when a patient is tested positive for leptospirosis using: 3) lateral flow; 4) MCAT; 5) latex test. Outcomes were measured in duration of fever which is then converted to productivity losses to capture the full economic costs. Empirical doxycycline treatment was found to be the most efficient strategy, being both the least costly alternative and the one that resulted in the lowest average duration of fever. The significantly higher relative cost of using a diagnostic test as compared with presumptive treatment, and the limited sensitivity of all the diagnostic tests implied that only the latex test could be considered cost-effective when compared with the no-antibiotic-treatment option, and that all three tests were still inferior to empirical treatment.Keywords
This publication has 22 references indexed in Scilit:
- Clinical spectrum of fever of intermediate duration in the south of SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Doxycycline versus Azithromycin for Treatment of Leptospirosis and Scrub TyphusAntimicrobial Agents and Chemotherapy, 2007
- LeptospirosisCurrent Opinion in Infectious Diseases, 2005
- Field application of Lepto lateral flow for rapid diagnosis of leptospirosisJournal of Medical Microbiology, 2003
- Assessment of the Clinical Presentation and Treatment of 353 Cases of Laboratory‐Confirmed Leptospirosis in Hawaii, 1974–1998Clinical Infectious Diseases, 2001
- Acute Lung Injury in Leptospirosis: Clinical and Laboratory Features, Outcome, and Factors Associated with MortalityClinical Infectious Diseases, 1999
- Microcapsule agglutination test for the diagnosis of leptospirosis in ThailandPathogens and Global Health, 1998
- The Markov Process in Medical PrognosisMedical Decision Making, 1983
- TREATMENT OF LEPTOSPIROSIS WITH OXYTETRACYCLINEPublished by Elsevier ,1958
- CHLORAMPHENICOL AND PENICILLIN IN THE TREATMENT OF LEPTOSPIROSIS AMONG BRITISH TROOPS IN MALAYAPublished by Elsevier ,1956